Cite
APA Citation
Hosomi, Y., Tanai, C., Yoh, K., Goto, Y., Sakai, H., Kato, T., Kaburagi, T., Nishio, M., Kim, Y. H., Inoue, A., Hasegawa, Y., Isobe, H., Tomizawa, Y., Mori, Y., Minato, K., Yamada, K., Ohashi, Y., & Kunitoh, H. (2018). characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression. Expert opinion on pharmacotherapy, 19, 1049–1056. http://access.bl.uk/ark:/81055/vdc_100066548796.0x00002c